RNA5SP206

Across TCGA pan-cancer cohorts, RNA5SP206 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RNA5SP206’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where RNA5SP206 RNA is repressed in tumor relative to normal tissue. In most cancer types RNA5SP206 is over-expressed in tumor, although a few such as BRCA and LUSC show the opposite, repressed pattern.

BRCA, LUSC, and THCA are the cancer types where RNA5SP206 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNA5SP206 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	III,IV	−0.530	<.001	6	view →
LUSC	All	All	−0.202	<.001	4	view →
THCA	All	III,IV	−0.278	.024	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RNA5SP206–BRCA

Open the BRCA breakdown →